March 2026 Issue

In this issue, we meet members of the Vaccine Insights editorial advisory board, including Senior Editor, Ingrid Kromann (CEPI). Plus, we get the latest on oral vaccine delivery with Vaxart's Sean Tucker and explore exciting new research into how mRNA vaccination affects antitumor immunity.

"Science and policy are inseparable; decisions in one domain reverberate across the other."
– Ingrid Kromann, Senior Advisor, Process Development and Manufacturing, CEPI

"COVID-19 mRNA vaccination should be explicitly accounted for when interpreting oncology datasets from that period."
– Adam Grippin, Physician-Scientist and Radiation Oncologist, MD Anderson Cancer Center